Skip to main content

Table 2 Outcome measures (adapted from [8])

From: Complex regional pain syndrome 1 – the Swiss cohort study

Assessments and Instruments

Baseline

6 weeks

3 months

6 months

12 months

24 months

Baseline Variables

      

Demographic variables

x

x

x

x

x

x

Disease related variables

x

     

Medication

x

x

x

x

x

x

Intoxication (smoking, alcohol)

x

     

Body Structure and Functions

      

Pain

      

   VAS diary pain

x

x

x

x

x

x

   Mc Gill pain questionnaire

x

x

x

x

x

x

Sensory symptoms

      

   Sensory testing [22]

x

x

x

x

x

x

Vasomotor

      

   Thermometry [23]

x

x

x

x

x

x

Sudomotor/edema

      

   Indirect volumetry [24]

x

x

x

x

x

x

Motor/trophic

      

   Range of motion [25]

x

x

x

x

x

x

   Dystonia (Fahn Marsden Scale) [26]+

x

x

x

x

x

x

TREND Symptoms Inventory [27]

x

x

x

x

x

x

Participation

      

Radboud Skills Questionnaire [28]* °

x

x

x

x

x

x

Walking Ability Questionnaire [29]"°

x

x

x

x

x

x

Rising & Sitting Ability Questionnaire [30]"°

x

x

x

x

x

x

Participation

      

Social Involvement Questionnaire [31]

x

  

x

x

x

Global Outcomes

      

SF-36 [32]

x

  

x

x

x

EQ-5D [33]

x

  

x

x

x

Environmental factors

      

Living situation, education, employment

x

x

x

x

x

x

Personal Factors

      

Tampa Scale of Kinesiophobia [34]

x

  

x

x

x

Hospital Anxiety & Depression scale [35]

x

  

x

x

x

Co-Morbidity [36]

x

  

x

x

x

  1. +The Fahn Marsden Score will only be used in patients with clinical signs of dystonia.
  2. *Only in patients with CRPS 1 in the upper extremity.
  3. "Only in patients with CRPS 1 in the lower extremity.
  4. °These questionnaires will be validated in German as a side project.